Freeman R B, Rohrer R J, Katz E, Lewis W D, Jenkins R, Cosimi A B, Delmonico F, Friedman A, Lorber M, O'Connor K, Bradley J
New England Medical Center/Tufts University School of Medicine, Division of Transplant Surgery, Box 40, 750 Washington St., Boston, MA 02111, USA.
Liver Transpl. 2001 Mar;7(3):173-8. doi: 10.1053/jlts.2001.22180.
Liver allocation remains problematic because current policy prioritizes status 2B or 3 patients by waiting time rather than medical urgency. On February 21, 2000, we implemented a variance to the United Network for Organ Sharing liver allocation policy that redefined status 2A by much more rigid, definable criteria and prioritized status 2B patients by using a continuous medical urgency score based on the Child-Turcotte-Pugh score and other medical conditions. In this system, waiting time is used only to differentiate status 2B candidates with equal medical urgency scores. Comparing the 6-month period (period 1; n = 67) before implementation of this system to the 6-month period after implementation (period 2; n = 75), there was a significant reduction in the number of transplantations performed for patients listed as status 2A (46.3% to 14.7%; P =.002) and an increase in the number of patients listed as status 2B who received transplants (44.8% to 70.7%; P =.10). Most dramatically, there was a 37.1% reduction in overall deaths on the waiting list from 94 deaths in period 1 to 62 deaths in period 2 (P =.005), with the most significant reduction for patients removed from this list at status 2B (52 v 18 patients; P =.04). There were 3 postoperative deaths in each period, with only 1 graft lost in period 2. Status 2B patients with the greatest degree of medical urgency received transplants without multiple peer reviews requesting elevation to 2A status. We conclude that a continuous medical urgency score system allocates donor livers much more fairly to those in medical need and reduces waiting list mortality without sacrificing efficacy.
肝脏分配仍然存在问题,因为当前政策按等待时间而非医疗紧迫性对2B级或3级患者给予优先考虑。2000年2月21日,我们对器官共享联合网络的肝脏分配政策进行了一项变通,通过更为严格、可定义的标准重新定义2A级,并根据Child-Turcotte-Pugh评分和其他医疗状况使用连续医疗紧迫性评分对2B级患者进行优先排序。在这个系统中,等待时间仅用于区分医疗紧迫性评分相同的2B级候选者。将该系统实施前的6个月期间(第1期;n = 67)与实施后的6个月期间(第2期;n = 75)进行比较,被列为2A级的患者接受移植的数量显著减少(从46.3%降至14.7%;P = 0.002),而被列为2B级且接受移植的患者数量增加(从44.8%增至70.7%;P = 0.10)。最显著的是,等待名单上的总死亡人数减少了37.1%,从第1期的94例死亡降至第2期的62例死亡(P = 0.005),其中2B级从名单上移除的患者死亡人数减少最为显著(从52例降至18例;P = 0.04)。每期有3例术后死亡,第2期仅1例移植物丢失。医疗紧迫性最高的2B级患者在无需多次同行评审要求提升至2A级的情况下接受了移植。我们得出结论,连续医疗紧迫性评分系统能更公平地将供体肝脏分配给有医疗需求的患者,并降低等待名单死亡率,同时不影响疗效。